These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 11358199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA, Rohr T, Ramirez LF, Meltzer HY.
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C.
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [Abstract] [Full Text] [Related]

  • 5. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M, Nomura S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
    [Abstract] [Full Text] [Related]

  • 6. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Ladha SS, Walker R, Shill HA.
    Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
    [Abstract] [Full Text] [Related]

  • 7. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

  • 8. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A, Ruiner CE, St-Laurent L, Hornstein D.
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome.
    Goldwasser HD, Hooper JF.
    Am Fam Physician; 1988 Nov; 38(5):211-6. PubMed ID: 3189125
    [Abstract] [Full Text] [Related]

  • 10. Malignant syndrome in Parkinson's disease: concept and review of the literature.
    Mizuno Y, Takubo H, Mizuta E, Kuno S.
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
    [Abstract] [Full Text] [Related]

  • 11. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
    Kumagai R, Harada T, Kurokawa K, Okazaki M, Egi N, Shimote K, Nakamura S.
    No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
    [Abstract] [Full Text] [Related]

  • 12. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Rascol O, Salachas F, Montastruc JL.
    Rev Neurol (Paris); 1990 Aug; 146(3):215-8. PubMed ID: 2184486
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome in advanced Parkinson's disease.
    Gordon PH, Frucht SJ.
    Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
    [Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Rainer C, Scheinost NA, Lefeber EJ.
    Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant-like syndrome: case report.
    Tibbels CK, Seegers S.
    Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
    [No Abstract] [Full Text] [Related]

  • 16. A hazardous side effect of neuroleptics: diagnosis and treatment.
    Epperly TD, McGlaughlin VG, Leo KU.
    Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232
    [Abstract] [Full Text] [Related]

  • 17. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P, Proppe D, Hoppe-Seyler S.
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract] [Full Text] [Related]

  • 18. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH, Feinberg SS, Feldman RG.
    JAMA; 1985 Nov 15; 254(19):2792-5. PubMed ID: 4057489
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
    Iwuagwu CU, Riley D, Bonoma RA.
    Am J Med; 2000 Apr 15; 108(6):517-8. PubMed ID: 10866587
    [No Abstract] [Full Text] [Related]

  • 20. Functional hyperthermia due to central dopaminergic impairment.
    Di Rosa AE, Morgante L, Coraci MA, Crisafulli A, Cacciola G, Di Stefano G, Meduri M, Di Perri R.
    Funct Neurol; 1988 Apr 15; 3(2):211-5. PubMed ID: 2900182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.